Nextage Therapeutics (Israel) Market Value
| MCTC Stock | ILA 74.90 3.60 4.59% |
| Symbol | Nextage |
Nextage Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nextage Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nextage Therapeutics.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Nextage Therapeutics on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Nextage Therapeutics or generate 0.0% return on investment in Nextage Therapeutics over 30 days. Nextage Therapeutics is related to or competes with B Yair, Aura Investments, Feat Fund, Sure Tech, Petrochemical, Hiron Trade, and ICL Israel. Micromedic Technologies Ltd develops and commercializes in-vitro cancer diagnostic products and solutions worldwide More
Nextage Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nextage Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nextage Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.97 | |||
| Information Ratio | 0.0763 | |||
| Maximum Drawdown | 40.45 | |||
| Value At Risk | (8.03) | |||
| Potential Upside | 12.0 |
Nextage Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nextage Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nextage Therapeutics' standard deviation. In reality, there are many statistical measures that can use Nextage Therapeutics historical prices to predict the future Nextage Therapeutics' volatility.| Risk Adjusted Performance | 0.0781 | |||
| Jensen Alpha | 0.5039 | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.0977 | |||
| Treynor Ratio | 0.7127 |
Nextage Therapeutics Backtested Returns
Nextage Therapeutics appears to be very steady, given 3 months investment horizon. Nextage Therapeutics has Sharpe Ratio of 0.0657, which conveys that the firm had a 0.0657% return per unit of risk over the last 3 months. We have found twenty-seven technical indicators for Nextage Therapeutics, which you can use to evaluate the volatility of the firm. Please exercise Nextage Therapeutics' Mean Deviation of 4.26, risk adjusted performance of 0.0781, and Downside Deviation of 4.97 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nextage Therapeutics holds a performance score of 5. The company secures a Beta (Market Risk) of 0.84, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Nextage Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Nextage Therapeutics is expected to be smaller as well. Please check Nextage Therapeutics' potential upside, semi variance, and the relationship between the value at risk and downside variance , to make a quick decision on whether Nextage Therapeutics' current price movements will revert.
Auto-correlation | 0.08 |
Virtually no predictability
Nextage Therapeutics has virtually no predictability. Overlapping area represents the amount of predictability between Nextage Therapeutics time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nextage Therapeutics price movement. The serial correlation of 0.08 indicates that barely 8.0% of current Nextage Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.08 | |
| Spearman Rank Test | -0.55 | |
| Residual Average | 0.0 | |
| Price Variance | 10.01 |
Nextage Therapeutics lagged returns against current returns
Autocorrelation, which is Nextage Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nextage Therapeutics' stock expected returns. We can calculate the autocorrelation of Nextage Therapeutics returns to help us make a trade decision. For example, suppose you find that Nextage Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nextage Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nextage Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nextage Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nextage Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Nextage Therapeutics Lagged Returns
When evaluating Nextage Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nextage Therapeutics stock have on its future price. Nextage Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nextage Therapeutics autocorrelation shows the relationship between Nextage Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Nextage Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nextage Stock
Nextage Therapeutics financial ratios help investors to determine whether Nextage Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nextage with respect to the benefits of owning Nextage Therapeutics security.